FOLLICULAR LYMPHOMA GRADE 3B
Clinical trials for FOLLICULAR LYMPHOMA GRADE 3B explained in plain language.
Never miss a new study
Get alerted when new FOLLICULAR LYMPHOMA GRADE 3B trials appear
Sign up with your email to follow new studies for FOLLICULAR LYMPHOMA GRADE 3B, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy shows promise for Tough-to-Treat lymphoma
Disease control OngoingThis study tests whether adding the drug mosunetuzumab to standard chemotherapy is safe and effective for people with aggressive B-cell lymphoma that has come back or not responded to prior treatment. About 24 adults will receive one of two chemotherapy backbones plus mosunetuzum…
Matched conditions: FOLLICULAR LYMPHOMA GRADE 3B
Phase: PHASE1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 17, 2026 13:53 UTC
-
Engineered donor cells take on Hard-to-Treat lymphomas
Disease control OngoingThis early-phase study tests a new treatment called P-CD19CD20-ALLO1 for people with certain types of B-cell lymphoma that have come back or not responded to standard therapy. The treatment uses donor immune cells that are specially designed to find and attack cancer cells. The m…
Matched conditions: FOLLICULAR LYMPHOMA GRADE 3B
Phase: PHASE1 • Sponsor: Poseida Therapeutics, Inc. • Aim: Disease control
Last updated May 13, 2026 15:59 UTC